Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Challis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2022
Current and emerging target identification methods for novel antimalarialsMatthew P Challis, Shane M Devine, Darren J Creek
Molecular & Cellular Proteomics : MCP|December 15, 2019
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>Geoffrey W Birrell, Matthew P Challis, Amanda De Paoli, et al.
European Journal of Medicinal Chemistry|May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarialsShane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
Elife|July 8, 2024
Chemoproteomics validates selective targeting of <i>Plasmodium</i> M1 alanyl aminopeptidase as an antimalarial strategyCarlo Giannangelo, Matthew P Challis, Ghizal Siddiqui, et al.
Nature Communications|September 27, 2024
Phosphoproteomics-directed manipulation reveals SEC22B as a hepatocellular signaling node governing metabolic actions of glucagonYuqin Wu, Ashish Foollee, Andrea Y Chan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2022
Current and emerging target identification methods for novel antimalarialsMatthew P Challis, Shane M Devine, Darren J Creek
Molecular & Cellular Proteomics : MCP|December 15, 2019
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against <i>Plasmodium falciparum</i>Geoffrey W Birrell, Matthew P Challis, Amanda De Paoli, et al.
European Journal of Medicinal Chemistry|May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarialsShane M Devine, Matthew P Challis, Jomo K Kigotho, et al.
Elife|July 8, 2024
Chemoproteomics validates selective targeting of <i>Plasmodium</i> M1 alanyl aminopeptidase as an antimalarial strategyCarlo Giannangelo, Matthew P Challis, Ghizal Siddiqui, et al.
Nature Communications|September 27, 2024
Phosphoproteomics-directed manipulation reveals SEC22B as a hepatocellular signaling node governing metabolic actions of glucagonYuqin Wu, Ashish Foollee, Andrea Y Chan, et al.
Pageof 1